Jeffrey B Kindler
Director · 7 filings · Latest: Aug 26, 2026
Praxis Precision Medicines, Inc.
PRECIGEN, INC.
Terns Pharmaceuticals, Inc.
| Ticker | Owner | Relationship | Date | Transaction | Cost | #Shares | Value ($) | #Shares Total | SEC Filing |
|---|---|---|---|---|---|---|---|---|---|
PGEN | Jeffrey B Kindler | Director | Aug 26, 2026 | Sale | $7.44 | 185,000 | $1.4M | 17,100 | |
PGEN | Jeffrey Kindler | — | Aug 26, 2026 | Proposed Sale | $7.42 | 185,000 | $1.4M | — | |
PRGO | KINDLER JEFFREY B | — | May 28, 2026 | Proposed Sale | $11.44 | 14,357 | $164.2K | — | |
PGEN | Jeffrey B Kindler | Director | Mar 13, 2026 | Option Exercise | — | 71,839 | — | 202,100 | |
PGEN | Jeffrey Kindler | — | Dec 12, 2025 | Proposed Sale | $3.69 | 235,467 | $868.9K | — | |
PGEN | Jeffrey Kindler | — | Sep 30, 2025 | Proposed Sale | $3.29 | 106,837 | $351.5K | — | |
PGEN | Jeffrey Kindler | — | Sep 29, 2025 | Proposed Sale | $3.63 | 67,523 | $245.1K | — | |
PRGO | KINDLER JEFFREY B | — | Dec 9, 2024 | Proposed Sale | $28.27 | 17,598 | $497.4K | — |